Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedMay 28, 2025
DataAggregated Company Financials
Companies9
  • 7D-0.03%
  • 3M-8.2%
  • 1Y10.4%
  • YTD3.4%

The Pharma industry has stayed flat over the last week. As for the the longer term, the industry is up 10% over the past 12 months. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 May 2025CHF 439.7bCHF 119.3bCHF 19.3b25.1x22.8x3.7x
Fri, 25 Apr 2025CHF 424.6bCHF 118.0bCHF 18.5b25.2x22.9x3.6x
Sun, 23 Mar 2025CHF 487.4bCHF 121.8bCHF 19.2b29.7x25.4x4x
Tue, 18 Feb 2025CHF 475.6bCHF 122.5bCHF 19.1b22.9x24.8x3.9x
Thu, 16 Jan 2025CHF 443.2bCHF 119.9bCHF 21.5b18.4x20.6x3.7x
Sat, 14 Dec 2024CHF 420.5bCHF 118.6bCHF 21.2b17.9x19.8x3.5x
Mon, 11 Nov 2024CHF 439.1bCHF 117.4bCHF 21.0b18.9x20.9x3.7x
Wed, 09 Oct 2024CHF 449.4bCHF 115.4bCHF 19.4b21.3x23.2x3.9x
Fri, 06 Sep 2024CHF 461.4bCHF 114.5bCHF 19.3b22.1x24x4x
Sun, 04 Aug 2024CHF 458.6bCHF 115.3bCHF 19.5b22.6x23.5x4x
Tue, 02 Jul 2024CHF 435.1bCHF 116.7bCHF 19.8b33.7x22x3.7x
Thu, 30 May 2024CHF 405.6bCHF 117.4bCHF 19.9b42.1x20.4x3.5x
Sat, 27 Apr 2024CHF 394.0bCHF 113.6bCHF 20.0b37.3x19.7x3.5x
Mon, 25 Mar 2024CHF 386.2bCHF 111.7bCHF 19.3b37.5x20x3.5x
Wed, 21 Feb 2024CHF 388.5bCHF 110.4bCHF 19.7b24.6x19.7x3.5x
Fri, 19 Jan 2024CHF 414.1bCHF 120.4bCHF 18.8b27x22x3.4x
Sun, 17 Dec 2023CHF 394.8bCHF 120.6bCHF 18.8b24.6x21x3.3x
Tue, 14 Nov 2023CHF 388.5bCHF 122.6bCHF 19.1b23.7x20.4x3.2x
Thu, 12 Oct 2023CHF 412.9bCHF 121.6bCHF 18.6b26.9x22.2x3.4x
Sat, 09 Sep 2023CHF 401.2bCHF 112.4bCHF 18.0b47.1x22.3x3.6x
Mon, 07 Aug 2023CHF 409.2bCHF 111.4bCHF 17.9b48.3x22.9x3.7x
Wed, 05 Jul 2023CHF 419.3bCHF 115.2bCHF 18.9b36.7x22.2x3.6x
Fri, 02 Jun 2023CHF 429.9bCHF 115.7bCHF 19.0b37.2x22.7x3.7x
Sun, 30 Apr 2023CHF 429.2bCHF 115.0bCHF 18.9b41x22.8x3.7x
Tue, 28 Mar 2023CHF 405.9bCHF 115.8bCHF 19.0b41.6x21.4x3.5x
Thu, 23 Feb 2023CHF 410.7bCHF 116.5bCHF 19.1b28.2x21.5x3.5x
Sat, 21 Jan 2023CHF 435.1bCHF 117.0bCHF 34.6b23.4x12.6x3.7x
Mon, 19 Dec 2022CHF 441.7bCHF 117.6bCHF 34.8b23.1x12.7x3.8x
Wed, 16 Nov 2022CHF 442.1bCHF 118.2bCHF 35.1b22.9x12.6x3.7x
Fri, 14 Oct 2022CHF 442.6bCHF 121.6bCHF 37.5b20.7x11.8x3.6x
Sun, 11 Sep 2022CHF 452.1bCHF 119.5bCHF 36.6b21.6x12.4x3.8x
Tue, 09 Aug 2022CHF 452.7bCHF 119.1bCHF 36.4b21.2x12.4x3.8x
Thu, 07 Jul 2022CHF 452.9bCHF 119.2bCHF 37.6b28.2x12x3.8x
Sat, 04 Jun 2022CHF 460.3bCHF 118.7bCHF 37.4b27.8x12.3x3.9x
Price to Earnings Ratio

12.3x


Total Market Cap: CHF 460.3bTotal Earnings: CHF 37.4bTotal Revenue: CHF 118.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 19.7x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 22.8x which is higher than its 3-year average PE of 19.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 20% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.47%
Healthcare-0.33%
Pharma-0.026%
Pharma-0.026%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 93.680.4%
+CHF 764.1m		2.8%PE17.2x
GALD Galderma GroupCHF 104.902.6%
+CHF 641.0m		43.9%PE130.3x
SDZ Sandoz GroupCHF 40.741.7%
+CHF 297.2m		26.2%PS2x
DESN Dottikon ES HoldingCHF 223.506.2%
+CHF 179.6m		-12.7%PE40.9x
CURN Curatis HoldingCHF 13.0020.4%
+CHF 11.0m		100.0%n/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

COPN

CHF 55.00

Cosmo Pharmaceuticals

7D

0.5%

1Y

-22.8%

CURN

CHF 13.00

Curatis Holding

7D

20.4%

1Y

100.0%

SDZ

CHF 40.74

Sandoz Group

7D

1.7%

1Y

26.2%

ROG

CHF 260.90

Roche Holding

7D

-0.9%

1Y

14.0%

GALD

CHF 104.90

Galderma Group

7D

2.6%

1Y

43.9%

Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%

May 20
Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%

NWRN

CHF 7.55

Newron Pharmaceuticals

7D

-2.8%

1Y

-21.4%

BIOV

CHF 34.40

BioVersys

7D

-2.8%

1Y

n/a

NOVN

CHF 93.68

Novartis

7D

0.4%

1Y

2.8%

Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

May 07
Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

ADXN

CHF 0.059

Addex Therapeutics

7D

2.8%

1Y

-13.0%

DESN

CHF 223.50

Dottikon ES Holding

7D

6.2%

1Y

-12.7%

Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

Feb 12
Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price